You are here

  • Home
  • Archive
  • Volume 9, Issue 3
  • Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

Article metrics

Article menu

Download PDFPDF

XML
Evidence based practice
Research
Efficacy, immunogenicity and safety of a recombinant tetravalent dengue vaccine (CYD-TDV) in children aged 2–17 years: systematic review and meta-analysis

 

Online download statistics by month:

Online download statistics by month: March 2019 to April 2024

AbstractFullPdf
Mar 2019762750146
Apr 201926425080
May 2019334331102
Jun 2019217206164
Jul 201921521073
Aug 201922221678
Oct 2019168161106
Nov 2019198195154
Dec 2019148131104
Jan 202012912183
Feb 202012512393
Mar 202010610382
May 2020625963
Jun 2020514756
Jul 2020595343
Aug 2020383439
Sep 2020656236
Oct 2020666437
Nov 2020706710
Dec 2020635931
Jan 2021555215
Feb 2021515118
Mar 2021989725
Apr 2021595818
May 2021737432
Jun 202110910824
Jul 2021726941
Aug 2021474928
Sep 2021474426
Oct 2021615445
Nov 2021272628
Dec 2021373427
Jan 2022292929
Feb 2022353617
Mar 2022525525
Apr 2022514717
May 2022424232
Jun 2022526041
Jul 2022434734
Aug 2022323115
Sep 2022383712
Oct 2022616443
Nov 2022363320
Dec 2022403519
Jan 2023262515
Feb 202330299
Mar 2023756428
Apr 202327225618
May 2023484412
Jun 2023292812
Jul 2023313014
Aug 2023383715
Sep 2023434630
Oct 2023797324
Nov 2023615319
Dec 2023684613
Jan 2024424124
Feb 2024504826
Mar 2024676035
Apr 2024221719
Total559053712524